Akebia Therapeutics Inc (AKBA) Q3 2020 Earnings Call Transcript
AKBA earnings call for the period ending September 30, 2020.
Akebia Therapeutics
AKBA
AKBA
$3.14
$0.09
3.0%
Price as of January 19, 2021, 9:00 p.m. EST
View Interactive AKBA Charts
AKEBIA THERAPEUTICS INC COM USD0.00001
Interactive Chart
News & Analysis: Akebia Therapeutics
Why Akebia Therapeutics Stock Is Crashing Today
The company's lead pipeline candidate fell short in a late-stage clinical study.
Akebia Therapeutics Inc (AKBA) Q1 2020 Earnings Call Transcript
AKBA earnings call for the period ending March 31, 2020.
Why Akebia Therapeutics Stock Is Crushing It Today
The biotech reported great news for its lead pipeline candidate.
2 Small-Cap Stocks That Could Double Your Money
Akebia Therapeutics and Satsuma Pharmaceuticals could both be big winners for early shareholders.
Why Akebia Therapeutics Stock Sank Today
The biotech provided a disappointing Q4 update.
Akebia Therapeutics Inc (AKBA) Q4 2019 Earnings Call Transcript
AKBA earnings call for the period ending December 31, 2019.
Why Akebia Therapeutics Stock Is Jumping Today
Momentum is continuing for the biotech after an announcement of positive clinical results and buying by key insiders earlier this month.
Why Akebia Therapeutics Stock Is Jumping Today
Insider buying is generating enthusiasm for this biotech stock among investors who aren't insiders.
$100 Million Loan Overshadows Akebia Therapeutics' Q3 Earnings Miss
The biotech's Q3 results weren't anything to crow about. But a big loan agreement will allow Akebia to fund operations until key clinical results are announced.
